FDA approves a new blood test to detect signs of Alzheimer’s

The Food and Drug Administration has approved a new blood test for Alzheimer’s that can detect a presence in the brain of amyloid plaque, which has been considered a key indicator of the disease. The test is not meant for routine screening but can be pivotal for a diagnosis when cognitive problems...

Redirecting to full article...